GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -690 | -3,109 | -867 | -549 | -249 |
| Depreciation Amortization | 50 | 154 | 58 | 38 | 18 |
| Accounts receivable | -137 | -26 | -68 | -43 | -113 |
| Accounts payable and accrued liabilities | 159 | -142 | -157 | -92 | -95 |
| Other Working Capital | 10 | -769 | -791 | -626 | -662 |
| Other Operating Activity | 123 | 1,799 | 233 | 143 | 216 |
| Operating Cash Flow | $-485 | $-2,093 | $-1,592 | $-1,129 | $-885 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -33 | -22 | -6 | -3 |
| Net Acquisitions | N/A | -2,808 | -88 | N/A | N/A |
| Purchase Of Investment | -3,060 | -3,060 | N/A | N/A | N/A |
| Sale Of Investment | 3,060 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3 | -172 | -171 | -131 | -59 |
| Other Investing Activity | -3 | -172 | -171 | -131 | -59 |
| Investing Cash Flow | $-10 | $-6,073 | $-281 | $-137 | $-62 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,660 | 3,060 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 285 | 283 | 273 | 273 |
| Other Financing Activity | -3,060 | 748 | 748 | 758 | 968 |
| Financing Cash Flow | $600 | $4,093 | $1,031 | $1,031 | $1,241 |
| Beginning Cash Position | 614 | 4,687 | 4,687 | 4,687 | 4,687 |
| End Cash Position | 719 | 614 | 3,845 | 4,452 | 4,981 |
| Net Cash Flow | $105 | $-4,073 | $-842 | $-235 | $294 |
| Free Cash Flow | |||||
| Operating Cash Flow | -485 | -2,093 | -1,592 | -1,129 | -885 |
| Capital Expenditure | -7 | -33 | -22 | -6 | -3 |
| Free Cash Flow | -492 | -2,126 | -1,614 | -1,135 | -888 |